From The Trussville Tribune staff reports
New Jersey drug manufacturer, Tris Pharma, sent out an “urgent recall notice” for infant Ibuprofen, which it supplies to several large retailers who sell the product under their store name.
The company voluntarily recalled three lots of “Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID)” on Wednesday due to the drug possibly containing higher amounts of ibuprofen than advertised.
The recalled drugs were sold at Walmart, CVS and Family Dollar locations under store-brand names, Tris Pharma said in a statement.
“To date, Tris Pharma Inc. has not received any reports of adverse events related to the lots of product that are the subject of this recall,” according to the statement issued by the company. “There is a remote possibility that infants, who may be more susceptible to a higher potency level of drug, and therefore may be more vulnerable to permanent NSAID-associated renal injury. Adverse effects that may be experienced are nausea, vomiting, epigastric pain, or more rarely, diarrhea. Tinnitus, headache and gastrointestinal bleeding are also possible adverse effects.”
